Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New bedwetting alarm tested against standard device – but trial cut short

NCT ID NCT05214131

Symptom relief Sponsor: Yale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared a new bedwetting alarm called GoGoband, which wakes a child before they wet the bed, to a standard alarm that sounds after wetting. The trial included 16 children aged 6 to 21 with bedwetting but no ADHD. However, the study was terminated early, so the results are too limited to draw firm conclusions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GoGoband device (biometric alarm) and standard Pflaundler bedwetting alarm
What this could lead to
If successful, this could show that a pre-wetting alarm reduces wet nights more effectively than standard alarms for children with bedwetting.
What could go wrong
The trial was terminated early with only 16 participants, so results are very limited. It is unclear if the device works better than standard alarms, and no statistical analysis was possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

16 people

The number who actually took part.

Started

Apr 2022

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 21 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or female, aged 6 to 21 years 4. In good general health as evidenced by medical history and diagnosed with MNE 5. Ability to and be willing to adhere to the treatment regimen. - Exclusion Criteria: 1. No patient may have had treatment of MNE in the past 6 months whether with medications or alarms 2. Current use of on ADHD medications, Tricyclics, SSRI's, NRI's or any antipsychotic medications. 3. Presence of Autistic Spectrum disorder, ADHD, genetic syndrome associated with developmental or learning disabilities 4. Treatment with another investigational drug or other intervention within last 6 months 5. Any form of Diabetes Mellitus or Diabetes Insipidus 6. No patient with known Chronic renal disease with moderate to severe renal impairment (defined as a creatinine clearance below 50mL/min). 7. No patient with known hyponatremia or a history of hyponatremia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bedwetting are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

enuresis nocturnal enuresis Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bedwetting Nocturnal enuresis Urinary incontinence

Contacts and locations

Locations

  • Yale New Haven Health

    New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.